U.S. Physical Therapy's (USPH) "Outperform" Rating Reaffirmed at Barrington Research

U.S. Physical Therapy (NYSE:USPH - Get Free Report)'s stock had its "outperform" rating reissued by equities researchers at Barrington Research in a report released on Thursday,Benzinga reports. They currently have a $108.00 price objective on the stock. Barrington Research's price target points to a potential upside of 13.33% from the stock's previous close.

A number of other research analysts also recently weighed in on USPH. Bank of America restated a "neutral" rating and set a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. StockNews.com upgraded shares of U.S. Physical Therapy from a "sell" rating to a "hold" rating in a report on Wednesday, August 21st.

U.S. Physical Therapy Stock Down 1.9 %

USPH stock traded down $1.80 during midday trading on Thursday, reaching $95.30. The company had a trading volume of 132,955 shares, compared to its average volume of 91,441. The company has a market capitalization of $1.44 billion, a P/E ratio of 90.46, a PEG ratio of 3.93 and a beta of 1.38. The company has a 50 day moving average of $83.21 and a two-hundred day moving average of $91.53. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.28. U.S. Physical Therapy has a 1 year low of $76.18 and a 1 year high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share for the quarter, missing analysts' consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to the consensus estimate of $163.34 million. U.S. Physical Therapy had a net margin of 4.06% and a return on equity of 8.18%. The firm's revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.76 EPS. On average, equities research analysts expect that U.S. Physical Therapy will post 2.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, COO Graham D. Reeve sold 1,724 shares of U.S. Physical Therapy stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the transaction, the chief operating officer now owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,724 shares of the firm's stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now directly owns 7,038 shares in the company, valued at $580,635. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Kathleen A. Gilmartin purchased 2,000 shares of the firm's stock in a transaction on Tuesday, September 3rd. The stock was bought at an average price of $86.09 per share, for a total transaction of $172,180.00. Following the completion of the transaction, the director now directly owns 18,904 shares in the company, valued at approximately $1,627,445.36. The trade was a 0.00 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.70% of the company's stock.

Institutional Trading of U.S. Physical Therapy

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Canada Pension Plan Investment Board acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter valued at about $28,000. Innealta Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter valued at about $30,000. Quest Partners LLC boosted its position in shares of U.S. Physical Therapy by 2,808.3% during the 2nd quarter. Quest Partners LLC now owns 349 shares of the company's stock valued at $32,000 after acquiring an additional 337 shares in the last quarter. Quarry LP boosted its position in shares of U.S. Physical Therapy by 1,291.9% during the 2nd quarter. Quarry LP now owns 515 shares of the company's stock valued at $48,000 after acquiring an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter valued at about $51,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.